These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1577978)

  • 61. Cytological differential diagnosis among adenocarcinoma, epithelial mesothelioma, and reactive mesothelial cells in serous effusions by immunocytochemistry.
    Su XY; Li GD; Liu WP; Xie B; Jiang YH
    Diagn Cytopathol; 2011 Dec; 39(12):900-8. PubMed ID: 20836004
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunoperoxidase staining of malignant cells in pleural effusions.
    Pastormerlo M
    Pathologica; 1990; 82(1080):421-5. PubMed ID: 2284143
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
    Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
    Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A simplified flow cytometric immunophenotyping procedure for the diagnosis of effusions caused by epithelial malignancies.
    Pillai V; Cibas ES; Dorfman DM
    Am J Clin Pathol; 2013 May; 139(5):672-81. PubMed ID: 23596119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improved identification of malignant cells in serous effusions using a small, robust panel of antibodies on paraffin-embedded cell suspensions.
    Grefte JM; de Wilde PC; Salet-van de Pol MR; Tomassen M; Raaymakers-van Geloof WL; Bulten J
    Acta Cytol; 2008; 52(1):35-44. PubMed ID: 18323273
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Tumor markers in the diagnosis of ascitic and pleural puncture fluids].
    Mezger J; Lamerz R; Arnholdt H; Huhn D; Wilmanns W
    Onkologie; 1986 Feb; 9(1):11-6. PubMed ID: 3523341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of immunocytochemical sensitivity between formalin-fixed and alcohol-fixed specimens reveals the diagnostic value of alcohol-fixed cytocentrifuged preparations in malignant effusion cytology.
    Ikeda K; Tate G; Suzuki T; Mitsuya T
    Am J Clin Pathol; 2011 Dec; 136(6):934-42. PubMed ID: 22095380
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ferritin levels in malignant effusions: a useful marker?
    Paydaş S; Sargin O; Ozbek S; Gürbüz E
    Eur J Cancer; 1990; 26(8):919. PubMed ID: 2145940
    [No Abstract]   [Full Text] [Related]  

  • 70. Further characterization, isolation and identification of the epithelial cell-surface antigen defined by monoclonal antibody AUA1.
    Durbin H; Rodrigues N; Bodmer WF
    Int J Cancer; 1990 Mar; 45(3):562-5. PubMed ID: 2307544
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Accessibility of antigenic sites recognized by AUA1, HMFG1 and HMFG2 monoclonal antibodies: its influence on antibody binding of live cells.
    Mooi WJ; Krausz T; Kirkland SC; Cross A; Epenetos AA
    Int J Biol Markers; 1987; 2(2):57-63. PubMed ID: 2454274
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mesothelium and Malignant Mesothelioma.
    Hiriart E; Deepe R; Wessels A
    J Dev Biol; 2019 Apr; 7(2):. PubMed ID: 30965570
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Update on special techniques in routine cytopathology.
    Buley ID
    J Clin Pathol; 1993 Oct; 46(10):881-5. PubMed ID: 8227400
    [No Abstract]   [Full Text] [Related]  

  • 74. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
    Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
    Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture.
    Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG
    Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.
    Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E
    J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of monoclonal antibodies AUA1 and BER EP4 with anti-CEA for detecting carcinoma cells in serous effusions and distinguishing them from mesothelial cells.
    Robinson RJ; Royston D
    Cytopathology; 1993; 4(5):267-71. PubMed ID: 8274664
    [TBL] [Abstract][Full Text] [Related]  

  • 78. AUA1: new immunocytochemical marker for detecting epithelial cells in body cavity fluids.
    Kocjan G; Sweeney E; Miller KD; Bobrow L
    J Clin Pathol; 1992 Apr; 45(4):358-9. PubMed ID: 1577978
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions.
    To A; Coleman DV; Dearnaley DP; Ormerod MG; Steele K; Neville AM
    J Clin Pathol; 1981 Dec; 34(12):1326-32. PubMed ID: 7035498
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.